Premium
Oruka Therapeutics Inc (ORKA)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| FMR LLC | Institution | 7 431 403 | 12,32% | US$ 462,83M | 2026-03-31 |
| VR Management, LLC | Institution | 4 148 428 | 6,88% | US$ 258,36M | 2026-03-31 |
| Fairmount Funds Management LLC | Institution | 3 705 262 | 6,14% | US$ 230,76M | 2026-04-30 |
| BlackRock, Inc. | Institution | 3 527 087 | 5,85% | US$ 219,67M | 2026-03-31 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 3 205 865 | 5,32% | US$ 199,66M | 2025-09-30 |
| Viking Global Investors LP | Institution | 2 666 690 | 4,42% | US$ 166,08M | 2026-03-31 |
| Fairmount Healthcare Co-Invest Iii L.P. | Institution | 2 573 308 | 4,27% | US$ 160,27M | 2026-04-30 |
| Paradigm Biocapital Advisors LP | Institution | 2 320 316 | 3,85% | US$ 144,51M | 2026-03-31 |
| RTW Investments, LP | Institution | 2 058 148 | 3,41% | US$ 128,18M | 2026-03-31 |
| RTW Master Fund, Ltd. | Institution | 2 058 147 | 3,41% | US$ 128,18M | 2025-02-15 |
| Deep Track Capital, LP | Institution | 2 034 203 | 3,37% | US$ 126,69M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 1 896 780 | 3,14% | US$ 118,13M | 2025-05-06 |
| Vanguard Capital Management, LLC | Institution | 1 859 631 | 3,08% | US$ 115,82M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 613 461 | 2,68% | US$ 100,49M | 2026-03-31 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | Institution | 1 600 014 | 2,65% | US$ 99,65M | 2025-09-17 |
| Remedium Capital Partners, Llc | Institution | 1 565 661 | 2,60% | US$ 97,51M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 1 395 501 | 2,31% | US$ 86,91M | 2026-03-31 |
| Fairmount Healthcare Fund II L.P. | Institution | 1 131 954 | 1,88% | US$ 70,50M | 2026-04-30 |
| Viking Global Opportunities Drawdown (Aggregator) LP | Institution | 1 066 676 | 1,77% | US$ 66,43M | 2025-09-17 |
| Polar Capital Holdings Plc | Institution | 1 047 693 | 1,74% | US$ 65,25M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 007 537 | 1,67% | US$ 62,75M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 999 763 | 1,66% | US$ 62,27M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 954 867 | 1,58% | US$ 59,47M | 2026-03-31 |
| Dr. Lawrence Klein | Initiés | 927 309 | 1,54% | US$ 57,75M | 2026-03-16 |
| Venrock Healthcare Capital Partners III, L.P. | Institution | 856 747 | 1,42% | US$ 53,36M | 2025-09-30 |
| Mercer Global Advisors Inc. | Institution | 802 470 | 1,33% | US$ 49,98M | 2026-03-31 |
| Avidity Private Master Fund I LP | Institution | 790 926 | 1,31% | US$ 49,26M | 2024-09-30 |
| Avidity Partners Management, L.P. | Institution | 760 424 | 1,26% | US$ 47,36M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 727 449 | 1,21% | US$ 45,31M | 2026-03-31 |
| Woodline Partners LP | Institution | 574 882 | 0,95% | US$ 35,80M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 533 340 | 0,88% | US$ 33,22M | 2026-03-31 |
| Bellevue Asset Management AG | Institution | 507 008 | 0,84% | US$ 31,58M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 499 673 | 0,83% | US$ 31,12M | 2026-03-31 |
| Synergy Asset Management, LLC | Institution | 476 196 | 0,79% | US$ 29,66M | 2026-03-31 |
| SR One Capital Management, LP | Institution | 430 330 | 0,71% | US$ 26,80M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 411 006 | 0,68% | US$ 25,60M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
